LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹93 Cr | ₹73 Cr | ₹69 Cr | ₹62 Cr | ₹51 Cr |
What is the latest Consolidated Net Profit of LINCOLN PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹93 Cr |
| Mar2024 | ₹73 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹62 Cr |
| Mar2021 | ₹51 Cr |
How is Consolidated Net Profit of LINCOLN PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹93 Cr | 27.99 | |
| Mar2024 | ₹73 Cr | 5.11 | |
| Mar2023 | ₹69 Cr | 11.41 | |
| Mar2022 | ₹62 Cr | 21.02 | |
| Mar2021 | ₹51 Cr | - | |
Compare Consolidated Net Profit of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,152.7 Cr | 4.9% | -8.7% | 2.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 4.9% |
-8.7% |
2.4% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses